Cite
HARVARD Citation
Ishii, H. et al. (2018). A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study. BMJ open gastroenterology. 5 (1), p. . [Online].